BRIEF-Capricor Therapeutics reports Q3 loss per share $0.12 By: Reuters: Company News November 08, 2017 at 16:05 PM EST * Capricor Therapeutics reports third quarter 2017 financial results and provides update on duchenne muscular dystrophy development program Read More >> Related Stocks: Capricor Therap